Cargando…
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung cancer cases. One strategy widely used to treat non-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854807/ https://www.ncbi.nlm.nih.gov/pubmed/32681833 http://dx.doi.org/10.1016/j.bcp.2020.114154 |